Detalhe da pesquisa
1.
Training the next generation of pharmacometric modelers: a multisector perspective.
J Pharmacokinet Pharmacodyn
; 51(1): 5-31, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37573528
2.
Semi-mechanistic population pharmacokinetic/pharmacodynamic modeling of a Plasmodium elongation factor 2 inhibitor cabamiquine for prevention and cure of malaria.
Antimicrob Agents Chemother
; 67(12): e0089123, 2023 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37966273
3.
Translation of liver stage activity of M5717, a Plasmodium elongation factor 2 inhibitor: from bench to bedside.
Malar J
; 21(1): 151, 2022 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35570264
4.
Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps.
Pulm Pharmacol Ther
; 71: 102080, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34592476
5.
Correction to: Training the next generation of pharmacometric modelers: a multisector perspective.
J Pharmacokinet Pharmacodyn
; 51(1): 89, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37670078
6.
The guard changes.
J Pharmacokinet Pharmacodyn
; 47(1): 3-4, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31993959
7.
Covariate modeling in pharmacometrics: General points for consideration.
CPT Pharmacometrics Syst Pharmacol
; 13(5): 710-728, 2024 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38566433
8.
Data standards for model-informed drug development: an ISoP initiative.
J Pharmacokinet Pharmacodyn
; 45(5): 659-661, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30046963
9.
Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands.
Lancet Infect Dis
; 23(10): 1164-1174, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37414066
10.
Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting beta2-agonist, in different ethnic populations.
Int J Clin Pharmacol Ther
; 50(8): 545-56, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22735463
11.
Pharmacometrics in tuberculosis: progress and opportunities.
Int J Antimicrob Agents
; 60(3): 106620, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35724859
12.
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1.
Cancer Chemother Pharmacol
; 90(4): 369-379, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36066618
13.
Characterization of exposure-response relationships of ipatasertib in patients with metastatic castration-resistant prostate cancer in the IPATential150 study.
Cancer Chemother Pharmacol
; 90(6): 511-521, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36305957
14.
Population pharmacokinetics of ethambutol in South African tuberculosis patients.
Antimicrob Agents Chemother
; 55(9): 4230-7, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21690284
15.
Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.
Br J Clin Pharmacol
; 72(1): 51-62, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21320152
16.
Population Pharmacokinetics of Ipatasertib and Its Metabolite in Cancer Patients.
J Clin Pharmacol
; 61(12): 1579-1591, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34273118
17.
Changing Body Weight-Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial Carcinoma.
Clin Pharmacol Ther
; 107(3): 588-596, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31553054
18.
Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1.
Clin Pharmacol Ther
; 108(3): 566-574, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31955412
19.
Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.
J Pharmacokinet Pharmacodyn
; 36(4): 297-315, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-19572188
20.
Population Pharmacokinetic Analysis of Bintrafusp Alfa in Different Cancer Types.
Adv Ther
; 36(9): 2414-2433, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31278692